BFA
ARLZ

BlackRock Fund Advisors’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

BlackRock Fund Advisors’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3.97M Buy
+900,339
New +$4.27M ﹤0.01% 3005
2016
Q2 		– Sell
-1,373,330
Closed -$4.88M – 4418
2016
Q1 		$4.88M Buy
+1,373,330
New +$7.08M ﹤0.01% 2759

Other funds holding ARLZ

PCM
PAR Capital Management Boston, Massachusetts $4.03B AUM 35.05% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
TLCM
Tiger Legatus Capital Management New York $62.4M AUM 24.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

BlackRock Fund Advisors's ARLZ Position: Q4 2016 in Review

BlackRock Fund Advisors opened a new position in Aralez Pharmaceuticals Inc. (ARLZ) in Q4 2016: 900,339 shares worth $3.97M. The stake represents ﹤0.01% of the portfolio and ranks #3005 among its holdings. This is a return to the name: BlackRock Fund Advisors previously reported a position in ARLZ as recently as Q1 2016.

BlackRock Fund Advisors first reported a position in ARLZ in Q1 2016 and has held it in 2 quarters since. The position peaked at $4.88M in Q1 2016. 83 funds tracked by Wall St. Rank hold ARLZ as of Q4 2016.

  • BlackRock Fund Advisors held 900,339 shares of Aralez Pharmaceuticals Inc. worth $3.97M as of Q4 2016.
  • Aralez Pharmaceuticals Inc. was a new BlackRock Fund Advisors position in Q4 2016.
  • Aralez Pharmaceuticals Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3005 holding.
  • BlackRock Fund Advisors first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and has held it in 2 quarters since.
  • BlackRock Fund Advisors's Aralez Pharmaceuticals Inc. position peaked at $4.88M in Q1 2016.
  • 83 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.